Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03018704 · ClinicalTrials.gov registry record · Phase 4
Topiramate Treatment of Alcohol Use Disorders in African Americans
A Phase 4 study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- Phase 4
- Development phase
- 79
- Enrollment target
NCT03018704: Clinical Trial Phase 4 study, sponsored by VA Office of Research and Development.
NCT03018704 is a Phase 4 study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03018704, a Phase 4 study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 79 participants
- Enrollment target
Study Summary
The focus of this application is on the improvement of services for African American (AAs) Veterans afflicted with an alcohol use disorder. The project focuses on the use of topiramate as a treatment for alcohol use disorders. Despite having lower rates of heavy drinking than European Americans (EAs), AAs have significantly higher rates of mortality from a variety of alcohol-related conditions, including liver cirrhosis, accidents, and violence. Despite the higher rates of morbidity and mortality, pharmacological treatments are understudied in this population and there is some evidence that medications are less preferred and less effective in AAs.
Interventions
- DRUG placebo
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2021-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03018704
The ClinicalTrials.gov registry entry for NCT03018704 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT03018704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03018704 about?
NCT03018704 is a clinical study titled "Topiramate Treatment of Alcohol Use Disorders in African Americans". The focus of this application is on the improvement of services for African American (AAs) Veterans afflicted with an alcohol use disorder. The project focuses on the use of topiramate as a treatment for alcohol use disorders. Despite having lower rates of heavy drinking than European Americans (EAs...
What is the current status of trial NCT03018704?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 79 participants. The study started on 2017-08-01. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03018704?
The interventions under investigation include: placebo (DRUG), Topiramate (DRUG).
Who is sponsoring clinical trial NCT03018704?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.